Author(s):
Teja Deshpande, Pratap Bhan Kaushik, Ruhan Shaikh, A.V. Tilak
Email(s):
teja.deshpande@dpu.edu.in , pratap.kaushik@dpu.edu.in , doctor.ruhan@gmail.com , av.tilak@dpu.edu.in
DOI:
10.52711/0974-360X.2024.00610 
Address:
Teja Deshpande1, Pratap Bhan Kaushik2*, Ruhan Shaikh3, A.V. Tilak4
1Associate Professor, Department of Pharmacology, Dr. D. Y. Patil Medical College Hospital and Research Centre, Pimpri, Pune – 411018.
2Assistant Professor, Department of Community Medicine, Dr. D.Y. Patil Medical College Hospital and Research Centre, Pimpri, Pune – 411018.
3PG Resident, Department of Pharmacology, Dr. D.Y. Patil Medical College Hospital and Research Centre, Pimpri, Pune – 411018.
4Professor and Head, Department of Pharmacology, Dr. D.Y. Patil Medical College Hospital and Research Centre, Pimpri, Pune – 411018.
*Corresponding Author
Published In:
Volume - 17,
Issue - 8,
Year - 2024
ABSTRACT:
The discovery of noncoding RNA based therapy has revolutionized the treatment options available for rare diseases. This is a step ahead of discovery of monoclonal antibodies in modern era of medicine. This works through regulation of gene expression through gene silencing. There are few challenges but potential solutions are emerging. We can look forward to this therapy in coming future pioneering a new frontier.
Cite this article:
Teja Deshpande, Pratap Bhan Kaushik, Ruhan Shaikh, A.V. Tilak. Noncoding RNA Therapeutics: Pioneering a new Frontier. Research Journal of Pharmacy and Technology. 2024; 17(8):3933-5. doi: 10.52711/0974-360X.2024.00610
Cite(Electronic):
Teja Deshpande, Pratap Bhan Kaushik, Ruhan Shaikh, A.V. Tilak. Noncoding RNA Therapeutics: Pioneering a new Frontier. Research Journal of Pharmacy and Technology. 2024; 17(8):3933-5. doi: 10.52711/0974-360X.2024.00610 Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-8-58
REFERENCES:
1. Pandey R, Singh AV et al; Proteins and peptide drugs: a brief review. Research J. Pharm. and Tech. 2009; 2(2): April.-June. 228-233.
2. Namdev N, Upadhyay S; Challenges and approaches for oral protein and peptide drug delivery. Research J. Pharm. and Tech. 2016; 9(3): Mar., 305-312.
3. Bhosale AV, Hardikar SR et al; Oligonucleotide based therapeutics:aptamers.Research J. Pharm. and Tech. 2009; 2 (3): July-Sept. 449-455.
4. Green D, Dalmay T, Chapman T. Microguards and micromessengers of the genome. Heredity (Edinb). 2016; Feb; 116(2): 125-34. doi: 10.1038/hdy.2015.84. Epub 2015 Sep 30. PMID: 26419338; PMCID: PMC4806885.
5. Dhuri K, Bechtold C, Quijano E, Pham H, Gupta A, Vikram A, Bahal R. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. J Clin Med. 2020; Jun 26; 9(6): 2004. doi: 10.3390/jcm9062004. PMID: 32604776; PMCID: PMC7355792.
6. Wang J, Tian T, Li X, Zhang Y. Noncoding RNAs Emerging as Drugs or Drug Targets: Their Chemical Modification, Bio-Conjugation and Intracellular Regulation. Molecules. 2022; Oct 9; 27(19): 6717. doi: 10.3390/molecules27196717. PMID: 36235253; PMCID: PMC9573214.
7. Ghosh S, Biswas A et al; Gene Silencing is one of the most efficient and Promising Functional Genomics tools.Research J. Science and Tech. 2020; 12(3).
8. Chandra R; miRNA: Biogenesis, Functions, Gene Targets, Prediction tools and Databases – A Review. Research J. Pharm. and Tech. 2017; 10(6).
9. V.Jayashree, Dr. Malarkodi Velraj; Breast Cancer and various Prognostic Biomarkers for the diagnosis of the disease: A Review. Research J. Pharm. and Tech. 10(9).
10. Gatta AK, Philip NV et al; Strategic design of potential siRNA molecules for in vitro Evaluation inABCG2 resistant Breast cancer and in vivo toxicity determination. Research J. Pharm. and Tech. 2021; 14(1).
11. Ali Adel Dawood, Bassam Ismaeel Jasim; The CRISPR genome editing process is an effective advancement of short-term cancer treatment. Research J. Pharmaceutical Dosage Forms and Tech. 2021; 13(1).
12. Bhoyar AP; Duchenne Muscular Dystrophy.International Journal of Nursing Education and Research. 2021; 9(4).
13. Winkle, M., El-Daly, S.M., Fabbri, M. et al. Noncoding RNA therapeutics — challenges and potential solutions. Nat Rev Drug Discov. 2021; 20; 629–651. https://doi.org/10.1038/s41573-021-00219-z.
14. Santosh Shinde, Gaurav K. et al. Nanocarriers for Effective si-RNA delivery. Research J. Pharm. and Tech. 2018; 11(9).